New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
IM Cannabis Corp.
IMCC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

9M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Aug 2025

9M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Aug 2025

2.96USD

Shape0.32 ( 12.12%)
Market Closed (as of Jul 03, 20:00 EDT)
favorite-chart

Relative Strenght

92
favorite-chart

Volume Buzz

-53%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

58%

Quote Panel

Shape
Updated July 6, 2025
1W 19.35 % 1M 11.70 % 3M 125.95 % 1Y 38.97 %

Key Metrics

Shape
  • Market Cap

    9.13M


  • Shares Outstanding

    3.09M


  • Share in Float

    1.58M


  • Dividende

    0


  • Earning Date

    13 Aug 2025


  • Price Target

    2.96


  • Average Volume

    254724


  • Beta

    2.385


  • Range

    1.29-7.12


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.imcannabis.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

IMCC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$91M

Shape625%

2026-Revenue

$0.46

Shape-616%

2026-EPS

$13M

Shape-2258%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-1.14
vs -14.40

Q3.23

arrow
arrow

N/A

-0.72
vs -3.00

Q4.23

arrow
arrow

N/A

-1.08
vs -1.32

Q1.24

arrow
arrow

N/A

-0.96
vs 0.12

Q2.24

arrow
arrow

N/A

-0.17
vs -1.14

Q3.24

arrow
arrow

N/A

-0.30
vs -0.72

Q4.24

arrow
arrow

N/A

-0.23
vs -1.08

Q1.25

arrow
arrow

+106%

0.06
vs -0.96

Q2.25

arrow
arrow

N/A

-0.19
vs -0.17

Q3.25

arrow
arrow

N/A

-0.03
vs -0.30

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-45%

13.2M  vs 23.8M

Q3.23

arrow
arrow

-13%

12.4M  vs 14.2M

Q4.23

arrow
arrow

-26%

10.7M  vs 14.5M

Q1.24

arrow
arrow

-8%

12.1M  vs 13.2M

Q2.24

arrow
arrow

+12%

14.8M  vs 13.2M

Q3.24

arrow
arrow

+12%

13.9M  vs 12.4M

Q4.24

arrow
arrow

+25%

13.3M  vs 10.7M

Q1.25

arrow
arrow

+4%

12.5M  vs 12.1M

Q2.25

arrow
arrow

+19%

17.5M  vs 14.8M

Q3.25

arrow
arrow

+48%

20.6M  vs 13.9M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+0%

0
vs -0.43

Q2.23

arrow
arrow

-18%

-0.18
vs 0

Q3.23

arrow
arrow

-32%

-0.32
vs -0.18

Q4.23

arrow
arrow

-23%

-0.23
vs -0.32

Q1.24

arrow
arrow

-59%

-0.59
vs -0.23

Q2.24

arrow
arrow

-43%

-0.43
vs -0.59

Q3.24

arrow
arrow

-15%

-0.15
vs -0.43

Q4.24

arrow
arrow

-19%

-0.19
vs -0.15

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

9

9
vs NA

NA

Q2.21

arrow
arrow

17

17
vs 9

89%

Q3.21

arrow
arrow

23

23
vs 17

35%

Q4.21

arrow
arrow

37

37
vs 23

61%

Q1.22

arrow
arrow

29

29
vs 37

-22%

Q2.22

arrow
arrow

21

21
vs 29

-28%

Q3.22

arrow
arrow

20

20
vs 21

-5%

Q4.22

arrow
arrow

1

1
vs 20

-95%

Earnings Growth

Latest News